Zhang, P.W., Chen, F.X., Li, D., Ling, W.H. and Guo, H.H. (2015) A CONSORT-Compliant, Randomized, Double- Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients with Nonalcoholic Fatty Liver Disease. Medicine (Baltimore), 94, e758.
http://dx.doi.org/10.1097/md.0000000000000758
被以下文章引用:
-
标题:
花色苷对非酒精性脂肪肝脂质代谢调控机制的研究进展The Regulation Mechanisms of Anthocyanins on Lipid Metabolism in Non-Alcoholic Fatty Liver
作者:
周方行, 张莉珂, 杨燕
关键字:
花色苷, 非酒精性脂肪肝, 脂代谢Anthocyanins, Non-Alcoholic Fatty Liver Disease, Lipid Metabolism
期刊名称:
《Hans Journal of Food and Nutrition Science》, Vol.4 No.4, 2015-11-11
摘要:
花色苷是一类具有多种生物活性的黄酮类化合物，它能够对多种疾病起到防治作用，其中包括非酒精性脂肪肝等慢性非传染性疾病。花色苷对非酒精性脂肪肝的脂代谢的调节作用，在该疾病的预防、诊断以及治疗等过程中均起到重要作用，其相关的作用机制更是近年来的研究热点。因此，本文就花色苷对非酒精性脂肪肝脂类代谢中的研究进展进行综述，并提出了今后的研究展望。
Anthocyanins are types of biological activity of flavonoids compounds. They can contribute to a va-riety of diseases’ prevention and treatment, including NAFLD and other chronic non-communicable diseases. The effects of anthocyanins through the regulation of lipid metabolism play important roles in prevention, treatment and related aspects in NAFLD. Therefore, we summarized the current research progress on anthocyanins of lipid metabolism in non-alcoholic fatty liver disease, as well as future research perspectives.